P2X3 receptor antagonists for treatment of pain
US8247401B2 · kind B2 · utility
2Cited by
2References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 29, 2008 |
| Grant date | Aug 21, 2012 |
| Priority date | — |
| Expiry date | Dec 7, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The subject invention relates to novel P2X3 receptor antagonists that play a critical role in treating disease states associated with pain, in particular peripheral pain, inflammatory pain, or tissue injury pain that can be treated using a P2X3 receptor subunit modulator.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.